ArticleFuture science OA2020

Overcoming negative predictions of microRNA expressions to gemcitabine response with FOLFIRINOX in advanced pancreatic cancer patients.

Konstantin Schlick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.